医学
肝切除术
围手术期
丙氨酸转氨酶
天冬氨酸转氨酶
随机对照试验
肝功能
内科学
胃肠病学
缺血
缺血预处理
外科
麻醉
切除术
碱性磷酸酶
酶
化学
生物化学
作者
Chun Tian,Hongni Tian,Wenlang Li,Jie Chen,Qiao Guo,Guangyou Duan,He Huang
摘要
ABSTRACT Background and Aims Remote ischemic conditioning (RIC) has shown promise in preclinical and clinical studies, but its effectiveness in reducing hepatic ischemia–reperfusion injuries (HIRIs) and enhancing postoperative recovery after hepatectomy remains uncertain. In this study, we aimed to evaluate the impact of perioperative RIC (PRIC) on postoperative recovery in patients undergoing hepatectomy. Methods A randomised controlled trial was performed. A total of 135 eligible patients were randomised to either a control group (sham RIC), a PRIC‐1 group (RIC once daily for 3 days starting on the day of surgery) or a PRIC‐2 group (RIC twice daily). The primary outcome was the time to 2 times the upper limit of normal (2ULN) alanine transaminase (ALT) levels post‐hepatectomy. Secondary outcomes included time to reach 2ULN for aspartate transaminase (AST) levels, the area under the concentration–time curve on postoperative Day 7 (AUC‐POD7) for ALT, AST, total bilirubin and lactic acid, as well as assessments of gastrointestinal function and postoperative complications. Results Median time to 2ULN ALT was shorter in the PRIC‐1 and PRIC‐2 groups than in the control group (PRIC‐1: 5.0 [3.5, 6.0] vs. control: 7.0 [7.0, 10.0] days, p < 0.001; PRIC‐2: 5.0 [4.0, 8.0] vs. control: 7.0 [7.0, 10.0] days, p < 0.001). The AUC‐POD7 for ALT and AST, time to 2ULN AST, time to gastrointestinal tolerance and postoperative complications were significantly improved in the PRIC groups compared with thecontrols. Conclusions PRIC is safe and effective in reducing HIRIs and enhancing recovery post‐hepatectomy. Once‐daily PRIC offers similar benefits to twice‐daily PRIC. Trial Registration NCT06130436 ( ClinicalTrials.gov )
科研通智能强力驱动
Strongly Powered by AbleSci AI